Immunologie et Nouveaux Concepts en Immunothérapie

Recent papers from Immunologie et Nouveaux Concepts en Immunothérapie

1. Redefining Acne as a Distinct Inflammatory Disease: Acne Is Not an Aesthetic IssueJEADV Clinical Practice · 2026
2. A wake‐up call for acneJournal of the European Academy of Dermatology and Venereology · 2026
3. Prevalence and impact of solar lentigines: An international surveyJournal of the European Academy of Dermatology and Venereology · 2026
4. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention – Update 2026European Journal of Cancer · 2026
5. Low-Grade Nasopharyngeal Papillary AdenocarcinomaThe American Journal of Surgical Pathology · 2026
6. Integrating Dermocosmetics Into Acne Care in Latin America.2026
7. Current knowledge and perspectives on the emerging Inquilinus limosus pathogenClinical Microbiology Reviews · 2026
8. The Effect of Myrtacine and Celastrol‐Enriched Extract on Cutibacterium acnes Extracellular VesiclesInternational Journal of Dermatology · 2025
9. Chimeric virus-like particles carrying the CLEC17A carbohydrate-recognition domain significantly reduce Macrobrachium rosenbergii nodavirus infection in Sf9 cellsScientific Reports · 2025
10. Injectable and degradable calcium phosphate/silanized hyaluronic acid composite foam for bone defect repair: A study in a Rabbit modelComposites Part B Engineering · 2025
11. Best microbiological practice recommendations for the diagnosis of peri-prosthetic joint infections: the CRIOGO bacteriology reference center networkAnnals of Clinical Microbiology and Antimicrobials · 2025
12. Performance of a Deep Learning Algorithm for Melanoma Classification Across Diverse Dermoscopic and Tele‐Dermatology DatasetsJEADV Clinical Practice · 2025
13. Contaminated sponges as source of Klebsiella pneumoniae prostatitis outbreak after transrectal ultrasound-guided prostate biopsyInternational Journal of Infectious Diseases · 2025
14. Obesity: A Modulator in Acne ManagementActa Dermato Venereologica · 2025
15. Standardized Infliximab Regimen to Treat Severe Central Nervous System Tuberculosis: A Case Series of 18 PatientsOpen Forum Infectious Diseases · 2025
16. A priori optimization of levofloxacin dose regimen based on a population pharmacokinetics model.2025
17. Synovial Biomarkers C-Reactive Protein and Calprotectin for Diagnosing Chronic Periprosthetic Joint Infection: A Prospective Multicenter EvaluationThe Journal of Arthroplasty · 2025
18. Advances in Longevity: The Intersection of Regenerative Medicine and Cosmetic DermatologyJournal of Cosmetic Dermatology · 2025
19. Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell CarcinomaNew England Journal of Medicine · 2025
20. COVID-19 and blood group-related antigens: can natural anti-carbohydrate antibodies provide innate protection from symptomatic SARS-CoV-2 infection?Frontiers in Medicine · 2025